USDA paves the way for a cure to X-disease with Symbiont project

02 Sep 2024
2196

Imagine being able to vaccinate your cherry trees to help them fight X-disease. 

A molecular biologist recently hired at the USDA’s Wapato, Washington laboratory has launched a research program aimed precisely at this—even though the scientist himself doesn’t fully embrace my analogy with a vaccine because plant immune systems are very different from those of animals. 

“It’s like a long, slow dose of antibiotics,” said Marco Pitino. Only the trees would produce their own medicine after inoculation with a genetically modified agrobacterium, which creates a small biofactory—patented and branded as Symbiont—on the trunk. 

“The agrobacterium is the best molecular biologist in the world, with 1 million years of experience,” Pitino said. “It introduces a gene to produce food for itself, to build its home. Now, the ones we’ve used in the laboratory are disarmed.... We keep the genes that create the structure and introduce a gene of interest.”

The result functions like a self-sufficient insulin patch, producing a steady dose of molecules that keeps the tree regulated. This analogy is courtesy of Kevin Hackett, the national program leader for the USDA’s Agricultural Research Service. 

“It’s a way to deliver different therapeuthics,” Hackett explained, who discussed the technology first tested in citrus and now being studied in many crops. “The Symbiont system promises to transform agriculture and address plant diseases (transmitted by vectors).”

It sounds like science fiction, but the Symbiont system developed by the USDA is proving promising in the citrus industry, where Pitino was part of a large research team working on the USDA’s $15 million National Institute of Food and Agriculture project: “Therapeutic Molecule Evaluation and Field Delivery Pipeline.”

As part of this project, scientists used new genetic technology to combat huanglongbing, also known as citrus greening or HLB. Field trials are underway as part of a regulatory review by the USDA Animal and Plant Health Inspection Service. 

Plants vs. Pathogens

To explain his research, Pitino starts with the basics of the arms race between plants and pathogens.

“Plants are constantly bombarded by fungi and bacteria, but they don’t get sick,” he said. What makes specific pathogens, like the X-disease phytoplasma or the HLB bacterium, successful enemies is that they have developed a chemical warfare to suppress their hosts' immune response. 

When plant cells recognize an invader, they usually release reactive oxygen, which burns a small hole in the plant tissue to prevent the pathogen from spreading, Pitino said. The pathogens have developed “effectors” that inhibit this response, turning the host into a nice home for themselves. 

To illustrate how powerful the effectors are, Pitino and his colleagues in Florida attempted an experiment to transfer an effector gene from the bacterium causing HLB into a small “lab rat” plant commonly used in laboratory experiments. Trained dogs that can recognize HLB-infected trees were able to identify plants expressing the effector gene, even though they were not infected with the pathogen itself. 

By studying the DNA of the X-disease phytoplasma, which has 466 genes, Pitino hopes to identify the effectors that give it its pathogenic power. So far, he is sifting through more than a dozen candidates using gene editing to express them in these lab plants and then observing what they do. 

Small Injections into the Trunk

Determining what a future Symbiont should produce to help combat X-disease requires a lot of trial and error. To conduct these tests in a greenhouse, Pitino has created a delivery system using a 3D-printed tube and a seal made with a sticky silicone sold as fishing bait. 

The method is inspired by the trunk injection approach that some Florida growers use to administer antibiotics, but it is scaled down for small greenhouse trees. 

During a visit by Good Fruit Grower in June, Pitino and lab technician Douglas Harper tested the system on a cherry tree using blue food dye. Twenty minutes later, the blue dye was evident in the veins of the flowers and young leaves, demonstrating that the dye was being transported, as desired, through the xylem.

Tests on Cherries

This spring, several Northwest nurseries donated over 2,000 cherry trees to Pitino’s new lab. “Now that we have the plants, we can really see how cherries perform with the Symbionts,” Pitino said. 

A new grant from the Washington Tree Fruit Research Commission also supports the work on cherries; the latest federal budget request for the USDA also seeks additional funds to study Symbiont technology at the Wapato laboratory, Cooper said.

To create a Symbiont, Pitino makes a small wound in the tree’s bark and inoculates it with a solution containing the engineered agrobacterium. He then covers it to protect it from light during its development. 

Around the laboratory, you can see potted cherry trees supporting engineered Symbionts to produce green fluorescent proteins that Pitino and Harper can track through the plant using black lights. The structure of the biofactory integrates into the plant’s vascular system, allowing molecules to flow, but without any exchange of DNA.

The DNA of the cultivated plant is not altered. This, Pitino and his colleagues hope, will help the Symbiont approach gain regulatory and ultimately industrial approval.

Read the full article: Good Fruit Grower
Image: Good Fruit Grower


Cherry Times - All rights reserved

What to read next

Jon Clark: commercial success will increasingly depend on how the cherries are sold

Markets

04 May 2026

In 2026, UK sweet cherries confirm growth, quality gains and steady retail demand. With production forecast at 8,000 tonnes, the key challenge will be diversifying across retail, wholesale and export to capture value during seasonal peaks while reducing waste and big discounting.

Management techniques affect the quality of the cherries

Tech management

06 Aug 2026

A Liaoning Academy of Agricultural Sciences study examines how harvest timing, growing area, greenhouse orientation and plastic films affect sugars, vitamin C, firmness, nutritional value and market quality in sweet cherries grown in northeastern China under cover.

In evidenza

Following its most challenging season ever, the Chilean cherry industry is aiming to regain its former glory

Markets

29 Sep 2026

After a difficult season, Chile aims to relaunch its cherries in China through higher quality, reputation management and new commercial strategies. The industry is also looking to India and the United States, while rebuilding consumer trust remains the main priority.

Varieties with lower chilling requirements are expanding the potential for Peruvian cherry production

Varieties

29 Sep 2026

Peru is assessing the potential for cherry production in high-altitude Andean areas, where climate, low-chill varieties and improved logistics could support the first commercial harvests and pave the way for future exports to high-value Asian markets such as China.

Tag Popolari